(MedPage Today) — A low baseline prostate-specific antigen (PSA) level in midlife was associated with a reduced long-term risk of prostate cancer, according to a German cohort study.
Among the 1,482 men with serum PSA levels less than 1.00 ng…
Source link : https://www.medpagetoday.com/hematologyoncology/prostatecancer/119718
Author :
Publish date : 2026-02-03 21:09:00
Copyright for syndicated content belongs to the linked Source.
